Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis

Guardado en:

Detalles Bibliográficos
Autores principales:	Alice Tzeng, Tony H Tzeng, Moshe C Ornstein
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/dae64e52781b44a2a1ebf06a7cb4e9d9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:dae64e52781b44a2a1ebf06a7cb4e9d9
record_format	dspace
spelling	oai:doaj.org-article:dae64e52781b44a2a1ebf06a7cb4e9d92021-11-22T11:00:07ZTreatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis10.1136/jitc-2021-0034732051-1426https://doaj.org/article/dae64e52781b44a2a1ebf06a7cb4e9d92021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e003473.fullhttps://doaj.org/toc/2051-1426Alice TzengTony H TzengMoshe C OrnsteinBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Alice Tzeng Tony H Tzeng Moshe C Ornstein Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
format	article
author	Alice Tzeng Tony H Tzeng Moshe C Ornstein
author_facet	Alice Tzeng Tony H Tzeng Moshe C Ornstein
author_sort	Alice Tzeng
title	Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_short	Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_full	Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_fullStr	Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_full_unstemmed	Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
title_sort	treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/dae64e52781b44a2a1ebf06a7cb4e9d9
work_keys_str_mv	AT alicetzeng treatmentfreesurvivalafterdiscontinuationofimmunecheckpointinhibitorsinmetastaticrenalcellcarcinomaasystematicreviewandmetaanalysis AT tonyhtzeng treatmentfreesurvivalafterdiscontinuationofimmunecheckpointinhibitorsinmetastaticrenalcellcarcinomaasystematicreviewandmetaanalysis AT moshecornstein treatmentfreesurvivalafterdiscontinuationofimmunecheckpointinhibitorsinmetastaticrenalcellcarcinomaasystematicreviewandmetaanalysis
_version_	1718417765365186560

Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis

Ejemplares similares